Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphomaRecruitingPhase 32026-08-04NCT07188558

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Lyell Immunopharma, Inc.3

36 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AdventHealthOrlandoUnited States29
Allegheny Health NetworkPittsburghUnited States35
Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-SalemUnited States17
Banner Md Anderson Cancer CenterGilbertUnited States121
Cedars-Sinai Medical CenterLos AngelesUnited States392
Cleveland Clinical Taussig Cancer CenterClevelandUnited States1
Colorado Blood Cancer InstituteDenverUnited States178
Duke Cancer InstituteDurhamUnited States9
HackensackHackensackUnited States1
Honor HealthScottsdaleUnited States27
Intermountain HealthcareSalt Lake CityUnited States3
Mayo Clinic ArizonaScottsdaleUnited States34
Mayo Clinic FloridaJacksonvilleUnited States105
Mayo Clinic RochesterRochesterUnited States133
MD Anderson Cancer CenterHoustonUnited States589
MedStar Georgetown University HospitalWashington D.C.United States204
Moffitt Cancer CenterTampaUnited States523
Northside HospitalAtlantaUnited States134
NorthwesternChicagoUnited States17
Oncology Hematology Care Clinical TrialsCincinnatiUnited States3
Roswell Park Comprehensive Cancer CenterBuffaloUnited States63
Scri Oncology PartnersNashvilleUnited States156
St. David's South Austin Medical CenterAustinUnited States11
Texas Transplant InstituteSan AntonioUnited States10
University of ArkansasLittle RockUnited States14